UPC_APP_10151/2025

METHOD OF TREATING PROLIFERATIVE DISORDERS AND OTHER PATHOLOGICAL CONDITIONS MEDIATED BY BCR-ABL, C-KIT, DDR1, DDR2 OR PDGF-R KINASE ACTIVITY

Procedural & sub-applicationsDocument Access (RoP262)Milan CDGenericCase Closed

2025-04-10Procedural onlyproceduralApplication RoP262.1 (b)
The Milan Central Division granted ALIUD PHARMA's application for access to pleadings filed in closed proceedings between Accord Healthcare and Novartis (EP 2 501 384) under R. 262.1(b) RoP, after Novartis withdrew its objection following settlement of the main proceedings.